Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 266

1.

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.

Martínez-Martínez E, Brugnolaro C, Ibarrola J, Ravassa S, Buonafine M, López B, Fernández-Celis A, Querejeta R, Santamaria E, Fernández-Irigoyen J, Rábago G, Moreno MU, Jaisser F, Díez J, González A, López-Andrés N.

Hypertension. 2019 Jan 7:HYPERTENSIONAHA11811874. doi: 10.1161/HYPERTENSIONAHA.118.11874. [Epub ahead of print]

PMID:
30612490
2.

Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice.

Peng Y, Chen B, Zhao J, Peng Z, Xu W, Yu G.

Biomed Pharmacother. 2019 Jan 3;111:624-630. doi: 10.1016/j.biopha.2018.12.095. [Epub ahead of print]

3.

Soluble ST2 and Galectin-3 and Progression of CKD.

Alam ML, Katz R, Bellovich KA, Bhat ZY, Brosius FC, de Boer IH, Gadegbeku CA, Gipson DS, Hawkins JJ, Himmelfarb J, Kestenbaum BR, Kretzler M, Robinson-Cohen C, Steigerwalt SP, Tuegel C, Bansal N.

Kidney Int Rep. 2018 Sep 21;4(1):103-111. doi: 10.1016/j.ekir.2018.09.013. eCollection 2019 Jan.

4.

Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction.

Yogasundaram H, Nikhanj A, Putko BN, Boutin M, Jain-Ghai S, Khan A, Auray-Blais C, West ML, Oudit GY.

J Am Heart Assoc. 2018 Nov 6;7(21):e009098. doi: 10.1161/JAHA.118.009098.

5.

Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.

Ferreira JP, Bauters C, Eschalier R, Lamiral Z, Fay R, Huttin O, Girerd N, Zannad F, Pinet F, Rossignol P.

ESC Heart Fail. 2018 Nov 20. doi: 10.1002/ehf2.12359. [Epub ahead of print]

PMID:
30460754
6.

Novel biomarkers of cardiovascular disease: Applications in clinical practice.

Lyngbakken MN, Myhre PL, Røsjø H, Omland T.

Crit Rev Clin Lab Sci. 2018 Nov 20:1-28. doi: 10.1080/10408363.2018.1525335. [Epub ahead of print]

PMID:
30457415
8.

Galectin-3 predicts response and outcomes after cardiac resynchronization therapy.

Andre C, Piver E, Perault R, Bisson A, Pucheux J, Vermes E, Pierre B, Fauchier L, Babuty D, Clementy N.

J Transl Med. 2018 Nov 3;16(1):299. doi: 10.1186/s12967-018-1675-4.

9.

Galectin-3 deficiency ameliorates fibrosis and remodelling in dilated cardiomyopathy mice with enhanced Mst1 signaling.

Nguyen MN, Ziemann M, Kiriazis H, Su Y, Donner DG, Zhao WB, Lu Q, Rafehi H, Sadoshima J, McMullen JR, El-Osta A, Du XJ.

Am J Physiol Heart Circ Physiol. 2018 Nov 2. doi: 10.1152/ajpheart.00609.2018. [Epub ahead of print]

PMID:
30387702
10.

The role of galectin-3 in heart failure and cardiovascular disease.

Zhong X, Qian X, Chen G, Song X.

Clin Exp Pharmacol Physiol. 2018 Oct 29. doi: 10.1111/1440-1681.13048. [Epub ahead of print]

PMID:
30372548
11.

A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy.

Sharma UC, Sonkawade SD, Spernyak JA, Sexton S, Nguyen J, Dahal S, Attwood KM, Singh AK, van Berlo JH, Pokharel S.

Circ Heart Fail. 2018 Aug;11(8):e004867. doi: 10.1161/CIRCHEARTFAILURE.117.004867.

PMID:
30354563
12.

Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis.

Anyfanti P, Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Dolgyras P, Galanopoulou V, Aslanidis S, Douma S.

Clin Cardiol. 2018 Oct 23. doi: 10.1002/clc.23105. [Epub ahead of print]

13.

Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery.

Wyler von Ballmoos M, Likosky DS, Rezaee M, Lobdell K, Alam S, Parker D, Owens S, Thiessen-Philbrook H, MacKenzie T, Brown JR.

BMC Nephrol. 2018 Oct 20;19(1):280. doi: 10.1186/s12882-018-1093-0.

14.

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure.

Testa M, Rosso GL, Ferreri C, Feola M.

Diseases. 2018 Sep 27;6(4). pii: E88. doi: 10.3390/diseases6040088.

15.

Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome.

Melenovsky V, Cervenka L, Viklicky O, Franekova J, Havlenova T, Behounek M, Chmel M, Petrak J.

Kidney Blood Press Res. 2018;43(5):1437-1450. doi: 10.1159/000493657. Epub 2018 Sep 20.

16.

Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study.

Djordjevic A, Dekleva M, Zivkovic M, Stankovic A, Markovic Nikolic N, Alavantic D, Djuric T.

Mol Biol Rep. 2018 Sep 18. doi: 10.1007/s11033-018-4384-4. [Epub ahead of print]

PMID:
30229476
17.

Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.

Stoica A, Şorodoc V, Lionte C, Jaba IM, Costache I, Anisie E, Tuchiluș C, Rusalim Petriș O, Sîrbu O, Jaba E, Ceasovschih A, Vâţă L, Şorodoc L.

J Int Med Res. 2018 Sep 17:300060518798257. doi: 10.1177/0300060518798257. [Epub ahead of print]

PMID:
30222016
18.

Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans.

Lin LY, Chun Chang S, O'Hearn J, Hui ST, Seldin M, Gupta P, Bondar G, Deng M, Jauhiainen R, Kuusisto J, Laakso M, Sinsheimer JS, Deb A, Rau C, Ren S, Wang Y, Lusis AJ, Wang JJ, Huertas-Vazquez A.

G3 (Bethesda). 2018 Nov 6;8(11):3499-3506. doi: 10.1534/g3.118.200655.

19.

Evolving Use of Biomarkers in the Management of Heart Failure.

Paul S, Harshaw-Ellis K.

Cardiol Rev. 2018 Sep 5. doi: 10.1097/CRD.0000000000000224. [Epub ahead of print]

PMID:
30192238
20.

Exploring collagen remodeling and regulation as prognosis biomarkers in stable heart failure.

Dupuy AM, Kuster N, Curinier C, Huet F, Plawecki M, Solecki K, Roubille F, Cristol JP.

Clin Chim Acta. 2018 Sep 1. pii: S0009-8981(18)30459-5. doi: 10.1016/j.cca.2018.08.042. [Epub ahead of print]

PMID:
30179616

Supplemental Content

Loading ...
Support Center